Histological treatment effect of preoperative thrapy/prognostic prediction scoring system for pancreatic cancer -A retrospective observation study-

Histological treatment effect of preoperative thrapy/prognostic prediction scoring system for pancreatic cancer -A retrospective observation study- - NAT-PC scoring study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035672

Enrollment

Registered

2019-01-25

Start date

2019-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who underwent preoperative treatment and surgery, and examination including tumor marker (CA19-9, DUPAN-2), MD-CT, diffusion weighted MRI, PET-CT prior to and after preoperative treayment regardless of tumor resectability.

Exclusion criteria

Exclusion criteria: Those who do not fall under the above.

Design outcomes

Primary

Measure	Time frame
To evaluate the prediction ability of treatment effect by scoring system with tumor marker (CA19-9, DUPAN-2), tumor size, whole tumor ADC value on diffusion-weighted MRI, and SUVmax value.	—

Secondary

Measure	Time frame
To evaluate the prediction ability of prognosis by scoring system with tumor marker (CA19-9, DUPAN-2), tumor size, whole tumor ADC value on diffusion-weighted MRI, and SUVmax value.	—

Countries

Japan

Contacts

Public ContactKen-ichi Okada

Wakayama Medical University Second Department of Surgery

okada@wakayama-med.ac.jp073-441-0613

Outcome results